Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin

Karl Winckel, Mark Daglish, David Pache, Samantha A Hollingworth

Research output: Contribution to journal › Article › Research › peer-review

Access to Document

@article{8edd1cb573c14e8f9f1d94eda32d63f4,

title = "Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin",

author = "Karl Winckel and Mark Daglish and David Pache and Hollingworth, {Samantha A}",

year = "2020",

month = sep,

day = "3",

doi = "10.1071/AH20060",

language = "English",

journal = "Australia and New Zealand Health Policy",

issn = "1743-8462",

publisher = "CSIRO Publishing",

}

TY - JOUR

T1 - Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin

AU - Winckel, Karl

AU - Daglish, Mark

AU - Pache, David

AU - Hollingworth, Samantha A

PY - 2020/9/3

Y1 - 2020/9/3

UR - http://www.scopus.com/inward/record.url?scp=85095998809&partnerID=8YFLogxK

U2 - 10.1071/AH20060

DO - 10.1071/AH20060

M3 - Article

C2 - 32878686

JO - Australia and New Zealand Health Policy

JF - Australia and New Zealand Health Policy

SN - 1743-8462

ER -